Trial Type: Larynx

BRUOG-435
Head and Neck Cancer Study Project in the Geriatric Population
Protocol Status: OPEN TO ACCRUAL
Trial Type: Head and Neck, Larynx, Lip, Oral Cavity and Pharynx
Contact: Ribizzi-Akhtar, Iole
IRibizziAkhtar@BrownHealth.org
BH-P-BOLT
A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Protocol Status: OPEN TO ACCRUAL
Trial Type: Head and Neck, Larynx, Lip, Oral Cavity and Pharynx
Contact: Birnbaum, Ariel
abirnbaum@BrownHealth.org